Cold Chain

Pharmaceutical Outsourcing Supply Chain Airplane and Control Tower

Many pharmaceuticals are climate-sensitive and require reliable supply chains. Cold chain storage and distribution provides a dependable means to maintain the integrity of drug substances and products.

Products that require sophisticated cold chain/supply chain services include modern biologic therapeutics such as monoclonal antibodies and vaccines, cellular and gene therapies, certain types of insulin, and some cancer treatments. Distribution methods must maintain a precise temperature range when transporting from the manufacturer to the patient.

Cold chain services include temperature-controlled storage, packaging and distribution facilities at ambient, refrigerated, frozen, ultra-frozen, vapor-phase liquid nitrogen and liquid-phase liquid nitrogen conditions.

Filter

Hide Filter

  • Contracting – A Key Component of a Strong Vendor Relationship

    Friday, March 17, 2017
    Contracting in any vendor relationship can raise its ugly head when the parties least need or expect it. It is a given in any outsourcing that a contract of some sort needs to be put in place; however, there should be more emphasis on the effort ... read more

  • The Dynamics of Outsourcing: A Bibliometric Study

    Friday, March 17, 2017
    The process of globalization expands the focus of outsourcing to all sectors of the economy. The main motive for the implementation of outsourcing strategy is to reduce production costs and to create competitive advantages both to the companies ... read more

  • An Evolution Is Underway - And Is Here To Stay - In Centralized Monitoring

    Friday, March 17, 2017
    International Council for Harmonisation Integrated Addendum to ICH E6 R1 - otherwise known as ICH E6 R21 - suggests centralized monitoring be incorporated as an important monitoring methodology in clinical trials. Different companies are taking ... read more

  • Clinical Trial Contracts: Language and Limitations

    Friday, March 17, 2017
    Contracts provided to study sites by industry sponsors contain legal language that is often confusing and not well understood by the study site representatives. This article reviews risk areas and contract language that sites should be familiar ... read more

  • The Rising Adoption of Technology in Clinical Trials

    Friday, March 17, 2017
    What’s been proven to reduce data variance, increase patient compliance and decrease site monitoring costs in clinical trials? For certain, it’s not the continued use of paper records. Digitization of clinical trial processes is the driving force ... read more

  • Multi-Site Clinical Partnerships: Bringing Together CROs, Sponsors and Hospitals

    Friday, March 17, 2017
    As the biopharmaceutical industry is facing a longer, more complex, and more expensive drug development process, all stakeholders must demonstrate flexibility and the ability to innovate and find solutions to overcome challenges. Patient ... read more

  • Data Trust and Transparency: New Era of Clinical Outsourcing and Partnerships

    Friday, March 17, 2017
    Demands today and into the next decade for more and better therapies is placing unprecedented pressure on the global pharmaceutical industry, and it is estimated that by 2020, up to three quarters of clinical trials are likely to be performed by CROs... read more

  • Cloud Computing.. Roundtable

    Wednesday, March 15, 2017
    What impact do you think the move to cloud computing will have on the ability of contract service organizations to better QQ meet the needs of their customers? read more

  • Spending on Contract Research Services Slowing Down

    Wednesday, March 15, 2017
    The 2017 Nice Insight Clinical Research Organization (CRO) Outsourcing Survey1 includes input from 608 outsourcing-facing pharmaceutical and biotechnology executives. The majority of the respondents are key decision makers; nearly one-third (31%)... read more

  • Supporting the Pharma Industry Small Business Growth Engine

    Wednesday, March 15, 2017
    The pharmaceutical industry looks very little as it did even a decade ago. Not only has the focus shifted from the development of blockbusters to drugs aimed at indications for smaller patient populations, the majority of new clinical candidates ... read more

  • Pharma’s Reputation Gap: Consumer Business Innovation

    Wednesday, March 15, 2017
    Headlines on exploitive pricing practices are just the most recent examples of pharma’s corporate social “irresponsibility” presented for public vilification. Right or wrong, pharma remains a perennial target and a popular bogeyman among ... read more

  • Local Vs. Global Manufacturing..Roundtable

    Wednesday, March 15, 2017
    What do CROs/CDMOs need to do to ensure that they provide effective global support but with locally oriented services? read more

  • New Requirements for Excipients...Roundtable

    Wednesday, March 15, 2017
    What will be the impact of the requirements that drug manufacturers gain a similar level of supply chain understanding for excipients as they must have for APIs? read more

  • Keeping the Chain Going

    Wednesday, March 15, 2017
    Clinical supply chain logistics form a crucial component of clinical trial infrastructure. The effectiveness and efficiency of a supply chain is directly related to the outcome of clinical trials. read more

  • Nice Insight: 2017 Industry Leaders

    Wednesday, March 15, 2017
    Nice Insight conducted seven annual studies to survey the pharma landscape and measure what buyers in the market want. These surveys were deployed to respondents in the diverse and dynamic sectors of CDMO, CRO, Equipment, Intermediate, ... read more
Page